Zebra Capital Management LLC Eagle Pharmaceuticals, Inc. Transaction History

Zebra Capital Management LLC

  • $20 Million
  • Q1 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$43.79 - $55.78 $283,408 - $361,008
-6,472 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$36.86 - $44.5 $25,728 - $31,061
-698 Reduced 9.74%
6,472 $277,000
Q1 2021

May 17, 2021
BUY
$40.32 - $50.97 $289,094 - $365,454
7,170 New
7,170 $299,000

Others Institutions Holding EGRX

# of Institutions
79
Shares Held
9.89M
Call Options Held
1.01M
Put Options Held
0
View Full List

About EAGLE PHARMACEUTICALS, INC.

EGRX Quotes by TradingView
  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $27.9M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Zebra Capital Management LLC Portfolio

Follow Zebra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email